Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients

Thrombosis and Haemostasis

Volumn 101, Issue 2, 2009, Pages 359-366

  Cranenburg, Ellen C M ^a   Brandenburg, Vincent M ^b   Vermeer, Cees ^a   Stenger, Melanie ^b   Mühlenbruch, Georg ^b   Mahnken, Andreas H ^b   Gladziwa, Ulrich ^c   Ketteler, Markus ^b   Schurgers, Leon J ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Calcification; Dialysis; Gla domain proteins; Matrix Gla protein; Vitamin K

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; OSTEOCALCIN; PROTEIN; CALCIUM BINDING PROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN;

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; AGED; ANGIOCARDIOGRAPHY; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DOWN REGULATION; GERMANY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PREDICTION AND FORECASTING; PROTEIN PROCESSING; RADIOGRAPHY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM-BINDING PROTEINS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GERMANY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 62449309045     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-024l     Document Type: Article

References (39)

1. US Renal Data System, USRDS 1998 annual data report, Bethesda: National Institute of Diabetes and Kidney Diseases 1999: 63-90.
2. US Renal Data System, USRDS 1998 annual data report, Bethesda; National Institute of Diabetes and Kidney Diseases 1999: 79-90.
3. Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monekeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176.
4. Lehto S, Niskanen L, Suhonen M, et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. ArteriosclerThromb Vasc Biol 1996: 16:978-983.
5. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942.
6. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrol Dial Transplant 2003; 18: 1731-1740.
7. London GM, Marchais SJ, Guerin AP, et al. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 2002: 17: 1713-1724.
8. Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15:1014-1021.
9. Raggi R Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701.
10. McCullough PA, Sandberg KR, Dumler F, et al. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004; 17: 205-215.
11. Luo G, D'Souza R, Hogue D, et al. The matrix Gla protein gene is a marker of the ehondrogenesis cell lineage during mouse development, J Bone Miner Res 1995: 10:325-334.
12. Wallin R, Cain D, Sane DC. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells - a cell system which resembles the system in bone cells. Thromb Haemost 1999; 82: 1764-1767.
13. El-Maadawy S, Kaartinen MT, Schinke T, et al. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003: 44: 272-278.
14. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990; 266: 625-636.
15. Schurgers LJ, Cranenburg ECM, Vermeer C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost 2008; 100: 593-603.
16. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125.
17. Cranenburg EC, Vermeer C, Koos R, et al. The circulating inactive form of Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45: 427-436.
18. Jie K.S, Bots ML, Vermeer C, et al. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis 1995; 116: 117-123.
19. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105.
20. Luo G, Ducy P. McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
21. Murshed M, Schinke T, McKee MD, et al. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004; 165: 625-630.
22. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 1629-1633.
23. Robinson J, Tan AU, Wilensky RL, et al. Electronbeam computerized tomography correlates with coronary angiogram in chronic kidney disease patients. Am J Nephrol 2007; 27: 247-252.
24. Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441.
25. Hermans MM, Vermeer C, Kooman JP, et al. Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Blood Purif 2007; 25: 395-401.
26. Hermans MM, Brandenburg V, Ketteler M, et al. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006; 21: 1293-1299.
27. Mahnken AH, Wildberger JE, Sinha AM, et al. Variation of the coronary calcium score depending on image reconstruction interval and scoring algorithm. Invest Radiol 2002; 37: 496-502.
28. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
29. Rumberger JA. Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999; 74: 243-252.
30. Goodman WG. Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
31. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 2001; 104: 2679-2684.
32. Barrett-Connor E, Laughlin GA, Connor C. Coronary artery calcium versus intima-media thickness as a measure of cardiovascular disease among asymptomatic adults (from the Rancho Bernardo Study). Am J Cardiol 2007; 99: 227-231.
33. Fair JM, Kiazand A, Varady A, et al. Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years. Am J Cardiol 2007; 100:981-985.
34. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-327.
35. Sweatt A, Sane DC, Hutson SM, et al. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003; 1: 178-185.
36. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
37. Schurgers LJ, Spronk HMH, Skepper JN, et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007; 5: 2503-2511.
38. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
39. Shroff RC, Shah V Hiorns MP, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008; 23: 3263-3272.